- Isis Pharma held a rescheduled conference call on 9/12/11 with a guest expert Dr. John Kastelein who recently presented long-term safety and efficacy data for mipomersen (Kynamro) at a scientific conference.
- Find detailed company and pipeline info on ISIS research page.
- See more biotech webcasts and links to my notes on Upcoming Events page.
- Click here to download PDF of the slide deck from the talk
- Follow this link to view my complete notes and analysis from this presentation, including some of the figures from the talk, as well as the extensive question and answer session.